Company Description
Wyeth is wise in the ways of health care. The company operates in three segments, the largest being its Pharmaceuticals business, which sells...
Key Wyeth Financials
| Company Type | Public - NYSE: WYE Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $22,399.8 |
| 2007 Employees | 50,527 |
More Wyeth Financials (11 pages)
Latest Wyeth Jobs powered by Monster.com
- Machinist
- Machinist
- Machinist
Rankings
- #113 in FORTUNE 500
- S&P 500
- #110 in FT Global 500
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Wyeth's competition across multiple industries
Top Wyeth Competitors
Sponsored Links
The Business Directory
Wyeth Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Robert A. (Bob) Essner | Network | E-mail |
| President, CEO, and Director | Bernard J. Poussot | Network | E-mail |
| SVP Corporate Business Development | Thomas Hofstaetter | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Wyeth News
-
Wyeth (NYSE:WYE) Weekly Earnings Information [Nelson Information - Weekly Domestic] (17 May 2008 01:01:00 EDT) - EUR: New meningococcal vaccine has good results in Aussies [AAP News (Australia)] (16 May 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (15 May 2008 23:00:00 EDT)
Latest Wyeth Video
-
Wyeth (WYE) President & COO Bernard Poussot (3:47)
07/19/07 5:40ET - Poussot discusses the company's better-than-expected earnings with CNBC's Maria Bartiromo.
Latest Industry Video
-
ASCO 2007 Preview (5:07)
06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.